Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device

Go back to Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device
(NASDAQ: DTSS) Delayed: 0.66 --0 (-0%)
Previous Close $0.66    52 Week High $8.90 
Open $0.70    52 Week Low $0.40 
Day High $0.70    P/E N/A 
Day Low $0.64    EPS $0.00 
Volume 5,240